MRSA colonisation in patients admitted with hip fracture: Implications for prevention of surgical site infection

Acta Orthopaedica Belgica

Volumn 75, Issue 2, 2009, Pages 252-257

  Thyagarajan, David ^a,b   Sunderamoorthy, Dakshinamurthy ^a   Haridas, Samarthjoy ^a   Beck, Sue ^a   Praveen, Pathmanaban ^a   Johansen, Anthony ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b University Hospital of Wales Cardiff and e NHS Trust Heath Heath ^*  (United Kingdom)

Author keywords

Femoral neck fracture; MRSA; Wound nfection in hip fractures

Indexed keywords

ANTIINFECTIVE AGENT; TEICOPLANIN;

AGED; ARTICLE; FEMALE; HIP FRACTURE; HOSPITAL ADMISSION; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HIP FRACTURES; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT ADMISSION; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; TEICOPLANIN;

EID: 67449106958     PISSN: 00016462     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ayliffe GAJ. Recommendations for the control of methi-cillin - resistant staphylococcus aureus. World Health Organisation, Division of emerging and other communicable diseases surveillance and control, 1996.
2. Ayliffe GAJ, Brumfitt W, Cooke EM et al. Report of combined working party of the hospital infection society and British society for antimicrobial chemotherapy. Revised guidelines for control of epidemic methicillin-resistant staphylococcus aureus. J Hosp Infect 1990 ; 6 : 351-377.
3. Coello R, Glynn JR, Gaspar C, Picazo JJ, Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus among hospital patients initially only colonised with MRSA. J Hosp Infect 1997 ; 37 : 39-46.
4. Cox RA, Bowie PES. Methicillin-resistant staphylococcus aureus colonisation in nursing home residents : a prevalence study in Northamptonshire. J Hosp Infect 1999 ; 43 : 115-122.
5. Crowcroft NS, Ronveaux O, Monnet DL, Mertens R. Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 1999 ; 20 : 31-36.
6. Di Filippo A, Simonetti T. Endonasal mupirocin in the prevention of nosocomial pneumonia. Minerva Anestesiol 1999 ; 65 : 109-113.
7. Fraise A P, Mitchell K, O'Brien S J, Oldfield K, Wise R. Methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes in a major UK city : an anonymised point prevalence survey. Epidemiol infect 1997 ; 118 : 1-5.
8. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D. Risk factors for persistent carriage of methicillin resistant Staphylococcus aureus. Clin Infect Dis 2000 ; 31 : 1380-1385.
9. Humphreys H. Comparison of infection caused by methi-cillin-sensitive and methicillin-resistant Staphylococcus aureus. In: Cafferkey MT (ed). Methicillin Resistant Staphylococcus Aureus. Clinical Management And Laboratory Aspects. Marcel Dekker, New York, 1992, pp 77-90.
10. Khan OA, Weston VC, Scammell BE. Methicillin-resistant Staphylococcus aureus incidence and outcome in patients with neck of femur fractures. J Hosp Infect 2002 ; 51 : 185-188.
11. Kusachi S, Sumiyama Y, Nagao J et al. New methods of control against postoperative methicilin-resistant staphylococcus aureus infection. Surgery Today 1999 ; 29 : 724-729.
12. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR.'Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999 ; 20 : 247-274.
13. Morgan M, Evans-Williams D, Salmon R etal. All Wales surveillance of methicillin-resistant Staphylococcus aureus (MRSA) The first year's results. J Hosp Infect 1999 ; 41 : 173-179.
14. Suetens C, Niclaes L, Jans B et al. Determinants of methicillin-resistant Staphylococcus aureus carriage in nursing homes. Age Ageing 2007 ; 36 : 327-330.
15. Tiemersma E, Bronzwaer S, Lyytikainen O et al. Methicillin-resistant Staphylococcus aureus in Europe 1999-2002. Emerg Infect Dis 2004 ; 10 : 1627-1634.
16. Voss A, Doebbeling BN. Worldwide prevalence of methi-cillin - resistant staph aureus. Int J Antimicrob Agents 1995 ; 5 : 101-106.
17. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003 ; 9 : 1415-1422.
18. Wood M. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 1996 37, 209-222.
19. Yano M, Doki Y, Inoue M et al. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing gastrointestinal surgery. Jpn J Surg 2000 ; 30 : 16-21.
20. Zulian C, Descamps P, Samyn B, Lemerle JP, Gaillot O. [Inquiry into incidence of nosocomial infections and evaluation of the transmission of methicillin-resistant Staphylococcus aureus in an orthopaedic surgical unit.] (in French). Pathologie Biologie 1999 ; 47 : 445-448.